Literature DB >> 19120368

Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms.

Tommaso Za, Alessia Fiorini, Elena Rossi, Angela Ciminello, Patrizia Chiusolo, Giuseppe Leone, Valerio De Stefano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19120368     DOI： 10.1111/j.1365-2141.2008.07537.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Influence of the JAK2 V617F Mutation and Inherited Thrombophilia on the Thrombotic Risk among Patients with Myeloproliferative Disorders.

Authors:  Mihaela Tevet; Razvan Ionescu; Cornel Dragan; Anca Roxana Lupu
Journal:  Maedica (Buchar)       Date:  2015-03

2.  Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg.

Authors:  Mandy N Lauw; Erik W N Bus; Alexander F Y van Wulfften Palthe; Michiel Coppens; Christa H Homburg; Saskia Middeldorp; C Ellen van der Schoot; Harry R Koene; Bart J Biemond
Journal:  Ann Hematol       Date:  2011-04-12       Impact factor: 3.673

3.  A Case Report of Large Bilateral Pulmonary Embolism in a Patient With Janus Kinase 2 (JAK2) Positive Mutation.

Authors:  Zahid Khan; George Besis
Journal:  Cureus       Date:  2022-05-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.